BASF increases prices for carbonyl chloride derivatives in Europe
Chemical

BASF increases prices for carbonyl chloride derivatives in Europe

With immediate effect or as contracts allow, BASF is increasing the sales prices for carbonyl chloride derivatives (CCDs) in Europe by 10 to 20 percent depending on the specific product. The price increase is necessary due to the increased production

  • By ICN Bureau | May 19, 2011

With immediate effect or as contracts allow, BASF is increasing the sales prices for carbonyl chloride derivatives (CCDs) in Europe by 10 to 20 percent depending on the specific product. The price increase is necessary due to the increased production costs.

The CCD portfolio of BASF comprises mainly acid chlorides and chloroformates, which are primarily used to make organic peroxides for the production of polymers. They are also important as intermediates for pharmaceuticals and agrochemicals. Further applications are cosmetics, soaps and detergents, mining chemicals, polymer additives and electroplating chemicals. Due to the special requirements of CCDs BASF offers its customers a host of consulting services, for example with respect to hazardous material handling.
 

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.